BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 19030927)

  • 1. Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis.
    Zhang Y; Li M; Wang H; Fisher WE; Lin PH; Yao Q; Chen C
    World J Surg; 2009 Apr; 33(4):698-709. PubMed ID: 19030927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis.
    Bloomston M; Frankel WL; Petrocca F; Volinia S; Alder H; Hagan JP; Liu CG; Bhatt D; Taccioli C; Croce CM
    JAMA; 2007 May; 297(17):1901-8. PubMed ID: 17473300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma.
    Nagao Y; Hisaoka M; Matsuyama A; Kanemitsu S; Hamada T; Fukuyama T; Nakano R; Uchiyama A; Kawamoto M; Yamaguchi K; Hashimoto H
    Mod Pathol; 2012 Jan; 25(1):112-21. PubMed ID: 21983937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis.
    Nakata K; Ohuchida K; Mizumoto K; Kayashima T; Ikenaga N; Sakai H; Lin C; Fujita H; Otsuka T; Aishima S; Nagai E; Oda Y; Tanaka M
    Surgery; 2011 Nov; 150(5):916-22. PubMed ID: 22018284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma.
    Liu Q; Chen J; Wang J; Amos C; Killary AM; Sen S; Wei C; Frazier ML
    Mol Carcinog; 2014 Sep; 53(9):711-21. PubMed ID: 23661430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma.
    Szafranska AE; Davison TS; John J; Cannon T; Sipos B; Maghnouj A; Labourier E; Hahn SA
    Oncogene; 2007 Jun; 26(30):4442-52. PubMed ID: 17237814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells.
    Kent OA; Mullendore M; Wentzel EA; López-Romero P; Tan AC; Alvarez H; West K; Ochs MF; Hidalgo M; Arking DE; Maitra A; Mendell JT
    Cancer Biol Ther; 2009 Nov; 8(21):2013-24. PubMed ID: 20037478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer.
    He H; Di Y; Liang M; Yang F; Yao L; Hao S; Li J; Jiang Y; Jin C; Fu D
    Oncol Rep; 2013 Aug; 30(2):651-8. PubMed ID: 23733161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
    Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
    Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EP300--a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas.
    Mees ST; Mardin WA; Wendel C; Baeumer N; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
    Int J Cancer; 2010 Jan; 126(1):114-24. PubMed ID: 19569050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific MAPK-Associated MicroRNAs in Serum Differentiate Pancreatic Cancer from Autoimmune Pancreatitis.
    Akamatsu M; Makino N; Ikeda Y; Matsuda A; Ito M; Kakizaki Y; Saito Y; Ishizawa T; Kobayashi T; Furukawa T; Ueno Y
    PLoS One; 2016; 11(7):e0158669. PubMed ID: 27380024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA expression aids the preoperative diagnosis of pancreatic ductal adenocarcinoma.
    Panarelli NC; Chen YT; Zhou XK; Kitabayashi N; Yantiss RK
    Pancreas; 2012 Jul; 41(5):685-90. PubMed ID: 22466166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA expression signatures in intraductal papillary mucinous neoplasm of the pancreas.
    Lubezky N; Loewenstein S; Ben-Haim M; Brazowski E; Marmor S; Pasmanik-Chor M; Oron-Karni V; Rechavi G; Klausner JM; Lahat G
    Surgery; 2013 May; 153(5):663-72. PubMed ID: 23305591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNAs in serum of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcinomas.
    Yabushita S; Fukamachi K; Tanaka H; Sumida K; Deguchi Y; Sukata T; Kawamura S; Uwagawa S; Suzui M; Tsuda H
    Pancreas; 2012 Oct; 41(7):1013-8. PubMed ID: 22513294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors.
    Jiao LR; Frampton AE; Jacob J; Pellegrino L; Krell J; Giamas G; Tsim N; Vlavianos P; Cohen P; Ahmad R; Keller A; Habib NA; Stebbing J; Castellano L
    PLoS One; 2012; 7(2):e32068. PubMed ID: 22384141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profiling identifies microRNA signature in pancreatic cancer.
    Lee EJ; Gusev Y; Jiang J; Nuovo GJ; Lerner MR; Frankel WL; Morgan DL; Postier RG; Brackett DJ; Schmittgen TD
    Int J Cancer; 2007 Mar; 120(5):1046-54. PubMed ID: 17149698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small nucleolar RNA U91 is a new internal control for accurate microRNAs quantification in pancreatic cancer.
    Popov A; Szabo A; Mandys V
    BMC Cancer; 2015 Oct; 15():774. PubMed ID: 26499892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
    Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
    Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model.
    Rachagani S; Macha MA; Menning MS; Dey P; Pai P; Smith LM; Mo YY; Batra SK
    Oncotarget; 2015 Nov; 6(37):40295-309. PubMed ID: 26516699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
    Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
    Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.